High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
15170359
DOI
10.1021/bi049928k
Knihovny.cz E-resources
- MeSH
- Transcriptional Activation MeSH
- Glutathione Transferase genetics metabolism MeSH
- DNA, Catenated chemistry metabolism MeSH
- Nucleic Acid Conformation MeSH
- Rats MeSH
- Humans MeSH
- Tumor Suppressor Proteins metabolism MeSH
- Tumor Suppressor Protein p53 chemistry metabolism MeSH
- Promoter Regions, Genetic genetics MeSH
- HMGB1 Protein chemistry metabolism MeSH
- Electrophoretic Mobility Shift Assay MeSH
- Cattle MeSH
- Substrate Specificity MeSH
- Protein Structure, Tertiary physiology MeSH
- Thymus Gland cytology MeSH
- Protein Binding physiology MeSH
- Binding Sites MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Glutathione Transferase MeSH
- DNA, Catenated MeSH
- Tumor Suppressor Proteins MeSH
- Tumor Suppressor Protein p53 MeSH
- HMGB1 Protein MeSH
We have recently observed that chromatin architectural protein HMGB1 (previously reported to be involved in numerous biological processes such as DNA replication, recombination, repair, tumor growth, and metastasis) could bind with extremely high affinity (K(d) < 1 pM) to a novel DNA structure that forms a DNA loop maintained at its base by a hemicatenane (hcDNA). The loop of hcDNA contains a track of repetitive sequences derived from CA-microsatellites. Here, we report using a gel-retardation assay that tumor-suppressor protein p53 can also bind to hcDNA. p53 is a crucial molecule protecting cells from malignant transformation by regulating cell-cycle progression, apoptosis, and DNA repair by activation or repression of transcription of its target genes by binding to specific p53 DNA-binding sites and/or certain types of DNA lesions or alternative DNA structures. The affinity of p53 for hcDNA (containing sequences with no resemblance to the p53 DNA consensus sequence) is >40-fold higher (K(d) approximately 0.5 nM) than that for its natural specific binding sites within its target genes (Mdm2 promoter). Binding of p53 to hcDNA remains detectable in the presence of up to approximately 4 orders of magnitude of mass excess of competitor linear DNA, suggesting a high specificity of the interaction. p53 displays a higher affinity for hcDNA than for DNA minicircles (lacking functional p53-specific binding sequence) with a size similar to that of the loop within the hcDNA, indicating that the extreme affinity of p53 for hcDNA is likely due to the binding of the protein to the hemicatenane. Although binding of p53 to hcDNA occurs in the absence of the nonspecific DNA-binding extreme carboxy-terminal regulatory domain (30-C, residues 363-393), the isolated 30-C domain (but not the sequence-specific p53 "core domain", residues 94-312) can also bind hcDNA. Only the full-length p53 can form stable ternary complexes with hcDNA and HMGB1. The possible biological relevance of p53 and HMGB1 binding to hemicatenanes is discussed.
References provided by Crossref.org
Progress in Assays of HMGB1 Levels in Human Plasma-The Potential Prognostic Value in COVID-19
The Rich World of p53 DNA Binding Targets: The Role of DNA Structure
Recognition of Local DNA Structures by p53 Protein
p53 Specifically Binds Triplex DNA In Vitro and in Cells
DNA and RNA quadruplex-binding proteins
Binding of histone H1 to DNA is differentially modulated by redox state of HMGB1
Cruciform structures are a common DNA feature important for regulating biological processes
HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity